(Q39332318)

11 September 2017

title

Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies (English)

1 reference

11 September 2017

1 reference

1 reference

1 reference

Zheng Guo

1

1 reference

11 September 2017

Alvin Chen

2

1 reference

11 September 2017

Roger A Nassar

3

1 reference

11 September 2017

Bernhard Helk

4

1 reference

11 September 2017

Claudia Mueller

5

1 reference

11 September 2017

Yu Tang

6

1 reference

11 September 2017

Kapil Gupta

7

1 reference

11 September 2017

Alexander M Klibanov

8

1 reference

11 September 2017

publication date

13 June 2012

1 reference

11 September 2017

published in

Pharmaceutical Research

1 reference

11 September 2017

volume

29

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

3102-3109

1 reference

Crystalline monoclonal antibodies for subcutaneous delivery

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Challenges in the development of high protein concentration formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

High-throughput dynamic light scattering method for measuring viscosity of concentrated protein solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Nature and consequences of protein-protein interactions in high protein concentration solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Protein drug stability: a formulation challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Reversible self-association of a human myeloma protein. Thermodynamics and relevance to viscosity effects and solubility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Milk proteins: physicochemical and functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0802-9

Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22692671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hydrophobic salts markedly diminish viscosity of concentrated protein solutions

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22692671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22692671

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11095-012-0802-9

1 reference

11 September 2017

1 reference